These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 20848462

  • 21. Implementation of the simple endoscopic activity score in crohn's disease.
    Koutroumpakis E, Katsanos KH.
    Saudi J Gastroenterol; 2016; 22(3):183-91. PubMed ID: 27184635
    [Abstract] [Full Text] [Related]

  • 22. Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level.
    Denis MA, Reenaers C, Fontaine F, Belaïche J, Louis E.
    Inflamm Bowel Dis; 2007 Sep; 13(9):1100-5. PubMed ID: 17508418
    [Abstract] [Full Text] [Related]

  • 23. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT.
    Louis E, Ancion G, Colard A, Spote V, Belaiche J, Hustinx R.
    J Nucl Med; 2007 Jul; 48(7):1053-9. PubMed ID: 17574978
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).
    Daperno M, Comberlato M, Bossa F, Biancone L, Bonanomi AG, Cassinotti A, Cosintino R, Lombardi G, Mangiarotti R, Papa A, Pica R, Rizzello F, D'Incà R, Orlando A.
    Dig Liver Dis; 2014 Nov; 46(11):969-73. PubMed ID: 25154049
    [Abstract] [Full Text] [Related]

  • 26. Intestinal wall thickness detected by multidetector spiral computed tomography enterography predicts the disease severity of Crohn's disease.
    Yang X, Yu L, Yu W, Tang M, He C, Li Z, Liu Z.
    Scand J Gastroenterol; 2014 Jul; 49(7):807-13. PubMed ID: 24730384
    [Abstract] [Full Text] [Related]

  • 27. Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) study.
    Volkers A, Bossuyt P, de Jong J, Pouillon L, Gecse K, Duijvestein M, Ponsioen C, D'Haens G, Löwenberg M.
    Scand J Gastroenterol; 2022 Apr; 57(4):439-445. PubMed ID: 34968158
    [Abstract] [Full Text] [Related]

  • 28. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG, Nieminen U, Turunen U, Arkkila P, Sipponen T, Färkkilä M.
    Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
    [Abstract] [Full Text] [Related]

  • 29. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T, López-García A, Rodríguez-Moranta F, Ruiz A, Rodríguez L, Guardiola J.
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease.
    E Penna FGC, Rosa RM, da Cunha PFS, de Souza SCS, de Abreu Ferrari ML.
    BMC Gastroenterol; 2020 Feb 13; 20(1):35. PubMed ID: 32054445
    [Abstract] [Full Text] [Related]

  • 32. Prediction of clinical outcomes in Crohn's disease by using confocal laser endomicroscopy: results from a prospective multicenter study.
    Tontini GE, Mudter J, Vieth M, Günther C, Milani V, Atreya R, Rath T, Nägel A, Hatem G, Sturniolo GC, Vecchi M, Neurath MF, Galle PR, Buda A, Neumann H.
    Gastrointest Endosc; 2018 Jun 13; 87(6):1505-1514.e3. PubMed ID: 29108979
    [Abstract] [Full Text] [Related]

  • 33. Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn's disease under treatment.
    Tajra JB, Calegaro JU, de Paula AP, Bachour D, Silveira D, Lozi M, Cavalcanti H.
    Scand J Gastroenterol; 2019 Apr 13; 54(4):441-445. PubMed ID: 30939952
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation.
    Coimbra AJ, Rimola J, O'Byrne S, Lu TT, Bengtsson T, de Crespigny A, Luca D, Rutgeerts P, Bruining DH, Fidler JL, Sandborn WJ, Santillan CS, Higgins PD, Al-Hawary MM, Vermeire S, Vanbeckevoort D, Vanslembrouck R, Peyrin-Biroulet L, Laurent V, Herrmann KA, Panes J.
    Aliment Pharmacol Ther; 2016 Jan 13; 43(1):61-72. PubMed ID: 26548868
    [Abstract] [Full Text] [Related]

  • 36. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
    Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, Sostegni R, Rocca R, Pera A, Gevers A, Mary JY, Colombel JF, Rutgeerts P.
    Gastrointest Endosc; 2004 Oct 13; 60(4):505-12. PubMed ID: 15472670
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
    Zubin G, Peter L.
    Inflamm Bowel Dis; 2015 Jun 13; 21(6):1386-91. PubMed ID: 25851564
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.